FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to ophthalmology, and covers treatment of eye diseases accompanied with development of stationary (inactive) form of submacular neovascular membrane (SNM) on retina. Exposure on eye represents a combination of laser coagulation and retrobulbar introduction of medicinal preparation Prospidinum 33 mg once a day within therapeutic course 5-10 days from the first day of laser coagulation, every 3-6 months.
EFFECT: invention allows for considerable reduction of SNM recurrence rate after retinal laser coagulation and treatments time, and improving social rehabilitation of the patients.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PROGRESSIVE (ACTIVE) SUBMACULAR NEOVASCULAR MEMBRANE (SNM) | 2008 |
|
RU2372087C1 |
| METHOD FOR TREATING SENILE MACULAR DEGENERATION AT NEOVASCULAR SYNDROME | 2003 |
|
RU2271208C2 |
| METHOD OF TREATMENT OF CHOROIDAL NEOVASCULATION | 2018 |
|
RU2676075C1 |
| METHOD OF QUANTITATIVE ESTIMATION OF CLINICAL EFFECTIVENESS OF PHOTODYNAMIC THERAPY IN CHOROIDAL NEOVASCULARISATION | 2008 |
|
RU2387471C1 |
| SURGERY TECHNIQUE FOR SUBRETINAL HAEMORRHAGES COMBINED WITH AGE-SPECIFIC MACULAR DYSTROPHY WITH SUBRETINAL NEOVASCULAR MEMBRANE | 2008 |
|
RU2366388C1 |
| METHOD CHOROIDAL NEOVASCULAR MEMBRANES PHOTODYNAMIC THERAPY | 2007 |
|
RU2333022C1 |
| COMBINED METHOD FOR TREATING CHOROIDAL NEOVASCULATION OF ALL TYPES | 2021 |
|
RU2770745C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF MYOPIC CHOROIDAL NEOVASCULARIZATION AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN MYOPIC EYES | 2020 |
|
RU2749120C1 |
| METHOD OF INCREASING EFFECIENCY OF PHOTODYNAMIC THERAPY OF CHOROIDAL NEOVASCULARISATION | 2008 |
|
RU2375023C1 |
| METHOD OF LASER TREATMENT OF FUSED DRUSEN IN CASE OF AGE-RELATED MACULAR DEGENERATION | 2011 |
|
RU2472476C1 |
